Credit Agricole S A Has $7.63 Million Stock Position in The Clorox Company $CLX

Key Points

• Credit Agricole S A increased its stake in The Clorox Company by 8.8%, now owning 51,844 shares valued at $7.63 million.
• Clorox recently announced a quarterly dividend increase from $1.22 to $1.24 per share, with a dividend yield of 4.1%.
• The company's earnings report showed an EPS of $2.87 for the latest quarter, surpassing estimates and reflecting a 4.5% year-over-year revenue growth.

Credit Agricole S A lifted its stake in The Clorox Company (NYSE:CLX - Free Report) by 8.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 51,844 shares of the company's stock after acquiring an additional 4,202 shares during the quarter. Credit Agricole S A's holdings in Clorox were worth $7,634,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Sonora Investment Management Group LLC increased its stake in Clorox by 2.5% during the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock worth $433,000 after acquiring an additional 72 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Clorox by 0.6% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock worth $1,953,000 after acquiring an additional 73 shares during the period. Horizon Investments LLC increased its stake in Clorox by 4.4% during the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock worth $258,000 after acquiring an additional 75 shares during the period. Sfmg LLC increased its stake in Clorox by 2.8% during the 1st quarter. Sfmg LLC now owns 2,780 shares of the company's stock worth $409,000 after acquiring an additional 76 shares during the period. Finally, Financial Avengers Inc. increased its stake in Clorox by 32.1% during the 4th quarter. Financial Avengers Inc. now owns 457 shares of the company's stock worth $74,000 after acquiring an additional 111 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on CLX. Citigroup restated a "neutral" rating and set a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Wells Fargo & Company lifted their price objective on shares of Clorox from $135.00 to $138.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the company an "underperform" rating in a research note on Tuesday, May 6th. Morgan Stanley decreased their price objective on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Finally, Barclays decreased their price objective on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research note on Tuesday, July 15th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, Clorox presently has an average rating of "Reduce" and an average target price of $143.36.

Clorox Stock Performance

NYSE CLX opened at $119.8040 on Friday. The firm's fifty day moving average price is $124.31 and its two-hundred day moving average price is $135.57. The stock has a market cap of $14.65 billion, a PE ratio of 18.37, a PEG ratio of 0.97 and a beta of 0.49. The Clorox Company has a fifty-two week low of $117.35 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company's revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be paid a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This is a boost from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. Clorox's payout ratio is presently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.